Trials / Terminated
TerminatedNCT06501898
Tributyrin: Time Course & Efficacy to Improve Health & Performance
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- Florida State University · Academic / Other
- Sex
- All
- Age
- 30 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine if tributyrin supplementation improves metabolite concentrations, overall health biomarkers, and performance in sedentary men and women. The study would further understand the potential usage of tributyrin as a health and performance increasing supplement through improving gut and immune health, sleep, and performance as well as reduce inflammation. Participants will supplement for tributyrin for 4 weeks and complete fecal metabolite measures, cardiovascular evaluation, sleep assessment, and exercise testing as well as provide blood samples.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | CoreBiome | 300 mg, once daily of tributyrin for 4 weeks |
| DIETARY_SUPPLEMENT | Placebo | 300 mg, once daily of placebo for 4 weeks |
Timeline
- Start date
- 2024-08-19
- Primary completion
- 2025-03-01
- Completion
- 2025-03-01
- First posted
- 2024-07-15
- Last updated
- 2025-04-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06501898. Inclusion in this directory is not an endorsement.